Telomerase activation and association with clinical variables were analyzed together with TERT expression, promoter mutation, and gene amplification using a series of 43 MCCs from 35 patients (Table 1 and Supplementary Table S1) and 6 MCC cell lines. This evidence concerns the gene TERT and Merkel cell skin cancer.